Canna~Fangled Abstracts Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease. Curr Neuropharmacol. 2018 Jul 2. doi: 10.2174/1570159X16666180702144644. Giuseppina T1, Alessandro T1, Giuseppe B1, de Lena…Freedom WaresJuly 2, 2018
Canna~Fangled Abstracts Endocannabinoid-Enhanced “Liking” in Nucleus Accumbens Shell Hedonic Hotspot Requires Endogenous Opioid Signals. Cannabis Cannabinoid Res. 2018 Jul 1;3(1):166-170. doi: 10.1089/can.2018.0021. eCollection 2018. Mitchell MR1, Berridge KC1, Mahler…Freedom WaresJuly 1, 2018
Canna~Fangled Abstracts The “Jay-Dar” Phenomenon: Individuals Discriminate Cannabis Users from Nonusers Based Upon a Photograph. Subst Use Misuse. 2018 Jun 29:1-9. doi: 10.1080/10826084.2018.1474228. Hirst RB1, Conaboy C1, Vaughn D1, H…Freedom WaresJune 29, 2018
Canna~Fangled Abstracts Appraising the “entourage effect”: antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochem Pharmacol. 2018 Jun 22. pii: S0006-2952(18)30238-7. doi: 10.1016/j.bcp.2018.06.025. Blasco-Benito S1, Seijo-Vila M2, Caro-Villalobos M2,…Freedom WaresJune 26, 2018
Canna~Fangled Abstracts The challenges of ‘medical cannabis’ and mental health: a clinical perspective. Br J Clin Pharmacol. 2018 Jun 20. doi: 10.1111/bcp.13687. Newton-Howes G1. Author information Abstract The…Freedom WaresJune 20, 2018
Canna~Fangled Abstracts Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC Journal List Med Cannabis Cannabinoids v.1(1); 2018 Jun PMC8489354 As a library, NLM provides access…Freedom WaresJune 16, 2018
Canna~Fangled Abstracts The Endocannabinoid System, Our Universal Regulator Research June 1, 2018 Access PDF AUTHORS: CHAD A. SALLABERRY AND LAURIE ASTERN Institutions: Department of…Freedom WaresJune 16, 2018
Canna~Fangled Abstracts Agricultural innovations in Morocco’s cannabis industry. Int J Drug Policy. 2018 Jun 6;58:85-91. doi: 10.1016/j.drugpo.2018.04.013. Chouvy PA1, Macfarlane J2. Author information…Freedom WaresJune 6, 2018
Canna~Fangled Abstracts Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington’s Disease. Methods Mol Biol. 2018;1780:549-571. doi: 10.1007/978-1-4939-7825-0_25. Bagher AM1,2, Laprairie RB1,3, Kelly MEM1,4, Denovan-Wright EM5. Author…Freedom WaresJune 2, 2018
Canna~Fangled Abstracts Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington’s disease. Neuropsychopharmacology. 2018 Jun 1. doi: 10.1038/s41386-018-0107-8. Covey DP1, Dantrassy HM1, Yohn SE2,3, Castro A1, Conn…Freedom WaresJune 1, 2018